Fineline Cube

Follow:
14389 Articles
Amgen’s UPLIZNA Wins European Approval for Generalized Myasthenia Gravis
CompanyDrug

Amgen’s UPLIZNA Wins European Approval for Generalized Myasthenia Gravis

CompanyDrug

Innovent Biologics Initiates Phase 3 HeriCare-Breast01 Study for IBI354 in HER2+ Breast Cancer

CompanyDeals

Ribo Life Science Licenses $4.4 Billion MASH siRNA Portfolio to Madrigal Pharmaceuticals

CompanyDeals

Novartis Secures Long-Term Actinium-225 Supply from Niowave for Radioligand Therapy Expansion

CompanyDeals

Therom Fisher’s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials

MSD’s Keytruda Wins FDA Approval for Platinum-Resistant Ovarian Cancer
CompanyDrug

MSD’s Keytruda Wins FDA Approval for Platinum-Resistant Ovarian Cancer

Sanofi Invests $30 Million in GluBio’s Sickle Cell TPD Programs
CompanyDeals

Sanofi Invests $30 Million in GluBio’s Sickle Cell TPD Programs

CompanyDrug

Henlius Biotech Initiates Phase Ib/II Study for HLX43 ADC Combinations in Colorectal Cancer

Jingxin Pharmaceutical Files Hong Kong IPO for Dual Listing Strategy
CompanyDeals

Jingxin Pharmaceutical Files Hong Kong IPO for Dual Listing Strategy

Novo Nordisk to Launch Wegovy Vial Version in Price War with Eli Lill
Company

Novo Nordisk to Launch Wegovy Vial Version in Price War with Eli Lilly

PANACRO Pharma Files Hong Kong IPO to Expand Digital Clinical Research Platform
Others

PANACRO Pharma Files Hong Kong IPO to Expand Digital Clinical Research Platform

Eli Lilly’s Jaypirca Wins NMPA Approval for CLL/SLL Post-BTK Inhibitor Therapy
CompanyDrug

Eli Lilly’s Jaypirca Wins NMPA Approval for CLL/SLL Post-BTK Inhibitor Therapy